Vitamin D and Endothelial Function
Top Cited Papers
Open Access
- 22 February 2020
- Vol. 12 (2), 575
- https://doi.org/10.3390/nu12020575
Abstract
Vitamin D is known to elicit a vasoprotective effect, while vitamin D deficiency is a risk factor for endothelial dysfunction (ED). ED is characterized by reduced bioavailability of a potent endothelium-dependent vasodilator, nitric oxide (NO), and is an early event in the development of atherosclerosis. In endothelial cells, vitamin D regulates NO synthesis by mediating the activity of the endothelial NO synthase (eNOS). Under pathogenic conditions, the oxidative stress caused by excessive production of reactive oxygen species (ROS) facilitates NO degradation and suppresses NO synthesis, consequently reducing NO bioavailability. Vitamin D, however, counteracts the activity of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase which produces ROS, and improves antioxidant capacity by enhancing the activity of antioxidative enzymes such as superoxide dismutase. In addition to ROS, proinflammatory mediators such as TNF-α and IL-6 are risk factors for ED, restraining NO and eNOS bioactivity and upregulating the expression of various atherosclerotic factors through the NF-κB pathway. These proinflammatory activities are inhibited by vitamin D by suppressing NF-κB signaling and production of proinflammatory cytokines. In this review, we discuss the diverse activities of vitamin D in regulating NO bioavailability and endothelial function.Funding Information
- National Heart, Lung, and Blood Institute (2R15HL113854-02)
This publication has 139 references indexed in Scilit:
- Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetesAtherosclerosis, 2013
- Vascular Endothelial Function and Hypertension: Insights and DirectionsCurrent Hypertension Reports, 2010
- A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolutionGenome Research, 2010
- Role of MCP-1 in tumor necrosis factor-α-induced endothelial dysfunction in type 2 diabetic miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Nuclear Factor-κB Activation Contributes to Vascular Endothelial Dysfunction via Oxidative Stress in Overweight/Obese Middle-Aged and Older HumansJournal of the American College of Cardiology, 2009
- Aging is associated with greater nuclear NFκB, reduced IκBα, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humansAging Cell, 2008
- Inflammation and endothelial dysfunction during aging: role of NF-κBJournal of Applied Physiology, 2008
- Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levelsDiabetic Medicine, 2008
- Vitamin D DeficiencyThe New England Journal of Medicine, 2007
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980